Zevra Therapeutics: Q4 Earnings Snapshot
Zevra Therapeutics: Q4 Earnings Snapshot
2 ‘Strong Buy’ Growth Stocks Poised for 141% to 193% Gains, According to Wall Street
The recent advancements in their pipelines imply high growth potential in the coming years.
Zevra Therapeutics, Inc. to be Added to Nasdaq Biotechnology Index Effective December 23, 2024
Zevra Therapeutics to join the Nasdaq Biotechnology Index effective December 23, enhancing its visibility in the biotech sector.Quiver AI SummaryZevra Therapeutics, Inc. announced that it will be added...